cyclocreatine has been researched along with Autism in 1 studies
cyclocreatine: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"Creatine Transporter Deficiency (CTD) is an inborn error of metabolism presenting with intellectual disability, behavioral disturbances and epilepsy." | 3.96 | Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency. ( Alessandrì, MG; Baroncelli, L; Battini, R; Butt, M; Cacciante, F; Cerri, E; Cioni, G; Do, MT; Gennaro, M; Lupori, L; Mazziotti, R; McKew, JC; Pizzorusso, T; Putignano, E; Sagona, G, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cacciante, F | 1 |
Gennaro, M | 1 |
Sagona, G | 1 |
Mazziotti, R | 1 |
Lupori, L | 1 |
Cerri, E | 1 |
Putignano, E | 1 |
Butt, M | 1 |
Do, MT | 1 |
McKew, JC | 1 |
Alessandrì, MG | 1 |
Battini, R | 1 |
Cioni, G | 1 |
Pizzorusso, T | 1 |
Baroncelli, L | 1 |
1 other study available for cyclocreatine and Autism
Article | Year |
---|---|
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Brain Diseases, Metabolic, Inborn; Cerebrovascular | 2020 |